FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
CHARLESTON, S.C. — Maude Callen, a Black nurse-midwife, delivered more than 800 infants across the South Carolina Lowcountry starting in
Read MoreWalgreen’s Boots Alliance on Tuesday slashed its full-year earnings guidance as it fell short of Wall Street expectations for its
Read MoreFederal regulators want most patients to see a health care provider in person before receiving prescriptions for potentially addictive medicines
Read MoreBethany Birch had pain in her diaphragm on and off for eight months in 2016. She knew it was triggered
Read MoreSource/Disclosures sources: Schroeder J, et al. Effects of decolonization protocols in pediatric critical care populations. Presented at: APIC 2023; June
Read MoreSource/Disclosures Published by: sources: Lapian B, et al. One team approach: Celebration of 300 days without a CLABSI as a
Read MorePavlo Gonchar | Light Rocket | Getty Images Pfizer on Monday said it would stop developing its experimental obesity and
Read MoreSUFFOLK, Va. — When Kristie Fields was undergoing treatment for breast cancer nine years ago, she got some unsolicited advice
Read MoreWhen the FDA first asserted the authority to regulate e-cigarettes in 2016, many people assumed the agency would quickly get
Read MoreRepublican presidential candidate and former US Vice President Mike Pence gestures during the “National Celebrate Life Day Rally” commemorating the
Read More